MB BS, FANZCA, FFPMANZCA, FCICM, GDipHlth&MedLaw
Scott graduated from Adelaide and toured Alice Springs, UK, and Africa before returning for specialist training. He then enjoyed five remarkable years in Townsville doing Anaesthetics and Pain Medicine, providing tertiary level care in a regional setting where anything and everything could present. The importance of a broadly skilled Intensive Care Service was obvious in this setting, and Scott was hopelessly drawn in. After completing ICU training, again in Adelaide, he gained additional paediatric ICU training at Sick Kids, Toronto, with elective time in echocardiography, palliative care, home ventilation, and ice-hockey.
From 2007-13 Scott became Staff Specialist in Anaesthetics and ICU at the Townsville Hospital, and Visiting PICU Consultant at Royal Children’s and Mater Children’s Hospitals in Brisbane. From 2014-16 he led the newly opened PICU in Townsville, achieving CICM accreditation in 2015. He also ran an outpatient paediatric ECHO service, incorporating rheumatic heart disease research with James Cook University.
Scott is passionate about enabling regional and rural health services. He helped develop Beyond Paeds BASIC, a course for senior, adult-trained clinicians who are forced to manage children occasionally. The course introduced him to Geelong, and he was so impressed he applied for a job!
Outside medicine Scott invests his energy in an environmentally sustainable farm forestry project in north Queensland. He plays a little music, and his grown up ‘little adults’ both attend Melbourne University. His long-suffering wife is a tertiary language teacher and ambassador for cultural diversity.
Head of Paediatric Critical Care
Prior to 2011, paediatric critical care consisted of time-critical resuscitation and rapid transfer to Melbourne. In response to increasing clinical demand we have now deliberately integrated paediatric clinical care into the core business of the ICU. Two bed spaces have been modified to suit this purpose, backed up by expanded stores of paediatric specific equipment, in-room teleconference capability, and augmented staff training and education programs.
We collaborate closely with our colleagues in Paediatrics, ED, and Special Care Nursery, and liaise with PIPER at Royal Children’s Hospital Melbourne, whenever patient acuity or complexity require it.
Barwon Health ICU coordinates high level educational programs, including Paediatric BASIC and High-SPAEDS courses, and is collaborating with Adelaide Women’s and Children’s Hospital in developing a bespoke PICU nursing transition course.
Barwon Health’s paediatric ICU data are submitted to ANZPICR for regular audit.
Latest news:
-
Thursday, August 26, 2021 - 01:57
JAMA BaSICS rate: Slower vs faster fluid challenge in critically ill patients not significantly reduce 90-day mortality. In addition there was a lower use of vasopressors on day 3 in the slower infusion rate group. Adds to SPLIT and SMART trials.
Monday, August 23, 2021 - 13:54NEJM Convalescent plasma RCT for high-risk patients present to ED within 7 days after the onset of symptoms = no difference disease progression
Monday, August 23, 2021 - 12:27NEJM VITT review 237 suspected from 24 million Oxford-Astra Zeneca doses, incidence at least 1:100,000 >50 years, 1:50,000 <50 years, occurs 5-30 days after first dose. Extensive thrombotic sites, cerebral venous thrombosis dominant. Low platelets, increased D-dimer, reduced fibrinogen associated worse outcomes. Overall case fatality rate 23%, highest in patients with both ICH and platelet count below 30,000. No therapeutic options proven effective, although IVIG, corticosteroids, plasma exchange, and non-heparin anticoagulation are used.
Sunday, August 22, 2021 - 19:03JC DOREMI RCT reports no difference in composite primary outcome with milrinone vs dobutamine for cardiogenic shock (49% M vs 54% D, RR, 0.90; 95% CI, 0.69 to 1.19; P=0.47). No difference in secondary outcomes. It was powered to detect a large effect.
Sunday, August 22, 2021 - 11:21REMAP-CAP, ACTIV-4a, and ATTACC harmonised multiplatform, randomized trial 2244 non-ICU patients with COVID- for every 1000 patients, therapeutic anticoagulation vs thromboprophylaxis expected to result in 40 additional patients surviving to hospital discharge without organ support, and 7 major bleeds.